Psychedelic Stocks

Study Identifies Where Psychedelics Users Find Reliable Information

Interest in psychedelics has increased greatly in the last decade or so, as new studies into the treatment of various mental health conditions using these drugs are conducted. As more positive benefits are discovered, we have seen changes to laws that previously prohibited access to the use of psychedelics as well as the emergence of psychedelic NGOs and psychedelic startups.

In an effort to inform harm reduction and education programs that address illicit and legal use of psychedelics, researchers looked into information-seeking behaviors of individuals who used psychedelics. The study was led by Dr. Daniel Kruger, a researcher at the Institute for Social Research. Its findings were published in the “Journal of Psychoactive Drugs.

The researchers were focused on examining the information sources used by individuals who used psychedelics in their natural environments and the degree to which they trusted this information. While official advice on the use of psychedelics by trained health professionals is scanty, we know that people who use psychedelics often engage in substantial gathering and sharing of information.

The researchers believe that the Schedule I classification of psychedelics has driven individuals to underground environments to seek information on harm reduction and guidance on how the drugs are to be used. For their research, the investigators carried out an anonymous online survey. They determined that users of psychedelics consulted different sources of information, all of which were not typical medical care and mainstream health systems.

Of the total study population, more than 80% had used at least two different psychedelics, with most of the participants having used the drugs at least once every six months in the last five years.

The researchers found that individual experiences and experimentation was the most common source of information on psychedelics for participants. Some also went to friends, websites, internet books and discussion forums as well as articles in peer-reviewed scientific journals.

In addition, the researchers found that fewer than 5% of the participants went to their primary healthcare providers, with an even smaller number admitting that they didn’t seek any information. Furthermore, the researchers observed that older individuals were more likely to seek information from psychedelic therapists, in comparison to younger participants.

In the report, Kruger noted that having trusted information sources was important as it heightened the likelihood of responsible and safe use. The researchers hope that their findings will help to better inform public health officials, policy makers and clinicians who work with psychedelic users.

Such studies showing how users of psychedelics are accessing information should give startups such as Compass Pathways PLC (NASDAQ: CMPS) plenty to think about regarding how best they can help members of the public gain access to reliable and timely information about this rapidly evolving industry.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Chris@PNW

Share
Published by
Chris@PNW

Recent Posts

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage

The company targets all current ketamine indications, including anesthesia and pain management. The U.S. is…

1 week ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network

The Kadima Neuropsychiatry Institute acquisition is part of NRx subsidiary HOPE Therapeutics’ model for a…

2 weeks ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Announces $10.3 Million Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval

Subsidiary HOPE Therapeutics signed a $7.8 million debt financing term sheet with Universal Capital. Combined…

3 weeks ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary, HOPE Therapeutics, to Expand Interventional Psychiatry Treatment with Kadima Institute Acquisition

Kadima Neuropsychiatry Institute is expected to become the clinical model for HOPE Therapeutics’ nationwide network…

4 weeks ago

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Is ‘One to Watch’

NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting multibillion-dollar unmet needs in central…

1 month ago

Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform

Rep. Morgan Luttrell (R-Texas), a retired Navy SEAL, is part of a rising wave of…

1 month ago